BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GILEAD SCIENCES, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

GILEAD SCIENCES, INC.

via GRIFFIN CONSULTING, LLC

4th Quarter (Oct 1 - Dec 31) · 2019Posted Jan 14, 2020Filing document ↗LDA record ↗

Income$70Kfee reported

Client

Name: GILEAD SCIENCES, INC.
Description: Research based biopharmaceutical company.
Location: District of Columbia · United States of America

Registrant

Firm: GRIFFIN CONSULTING, LLC
Description: Consulting firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement.
LobbyistsANNA GRIFFIN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.